Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure)Novelty and Significance [Clinical Track]

Publication Date:
2018-06-08
Publisher:
American Heart Association (AHA)
Print ISSN:
0009-7330
Electronic ISSN:
1524-4571
Topics:
Medicine
Keywords:
Cell Therapy, Clinical Studies, Stem Cells, Chronic Ischemic Heart Disease, Heart Failure
Published by: